The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
GDNF Secreting Human Neural Progenitor Cells Protect Dying Motor Neurons, but Not Their Projection to Muscle, in a Rat Model of Familial ALS
Open accessAbstract
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a fatal, progressive neurodegenerative disease characterized by rapid loss of muscle control and eventual paralysis due to the death of large motor neurons in the brain and spinal cord. Growth factors such as glial cell line derived neurotrophic factor (GDNF) are known to protect motor neurons from damage in a range of models. However, penetrance through the blood brain barrier and delivery to the spinal cord remains a serious challenge. Although there may be a primary dysfunction in the motor neuron itself, there is also increasing evidence that excitotoxicity due to glial dysfunction plays a crucial role in disease progression. Clearly it would be of great interest if wild type glial cells could ameliorate motor neuron loss in these models, perhaps in combination with the release of growth factors such as GDNF. METHODOLOGY/PRINCIPAL FINDINGS: Human neural progenitor cells can be expanded in culture for long periods and survive transplantation into the adult rodent central nervous system, in some cases making large numbers of GFAP positive astrocytes. They can also be genetically modified to release GDNF (hNPC(GDNF)) and thus act as long-term 'mini pumps' in specific regions of the rodent and primate brain. In the current study we genetically modified human neural stem cells to release GDNF and transplanted them into the spinal cord of rats over-expressing mutant SOD1 (SOD1(G93A)). Following unilateral transplantation into the spinal cord of SOD1(G93A) rats there was robust cellular migration into degenerating areas, efficient delivery of GDNF and remarkable preservation of motor neurons at early and end stages of the disease within chimeric regions. The progenitors retained immature markers, and those not secreting GDNF had no effect on motor neuron survival. Interestingly, this robust motor neuron survival was not accompanied by continued innervation of muscle end plates and thus resulted in no improvement in ipsilateral limb use. CONCLUSIONS/SIGNIFICANCE: The potential to maintain dying motor neurons by delivering GDNF using neural progenitor cells represents a novel and powerful treatment strategy for ALS. While this approach represents a unique way to prevent motor neuron loss, our data also suggest that additional strategies may also be required for maintenance of neuromuscular connections and full functional recovery. However, simply maintaining motor neurons in patients would be the first step of a therapeutic advance for this devastating and incurable disease, while future strategies focus on the maintenance of the neuromuscular junction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gage, F. H. (2000) · Science · doi:10.1126/science.287.5457.1433 · Cited by 4,786
A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes
Reynolds, B., Tetzlaff, W., & Weiss, S. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-11-04565.1992 · Cited by 1,509
Stem Cells in the Central Nervous System
McKay, R. (1997) · Science · doi:10.1126/science.276.5309.66 · Cited by 1,472
Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis
Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., & Kuncl, R. W. (1995) · Annals of Neurology · doi:10.1002/ana.410380114 · Cited by 1,471
Astroglia induce neurogenesis from adult neural stem cells
Song, H., Stevens, C. F., & Gage, F. H. (2002) · Nature · doi:10.1038/417039a · Cited by 1,452
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
Boillée, S., Vande Velde, C., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,429
From charcot to lou gehrig: deciphering selective motor neuron death in als
Cleveland, D. W., & Rothstein, J. D. (2001) · Nature Reviews Neuroscience · doi:10.1038/35097565 · Cited by 1,389
Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man
Fischer, L. R., Culver, D. G., Tennant, P., Davis, A. A., Wang, M., Castellano-Sanchez, A., Khan, J., Polak, M. A., & Glass, J. D. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.10.004 · Cited by 1,357
Bruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341
GDNF: a Potent Survival Factor for Motoneurons Present in Peripheral Nerve and Muscle
Henderson, C. E., Phillips, H. S., Pollock, R. A., Davies, A. M., Lemeulle, C., Armanini, M., Simmons, L., Moffet, B., Vandlen, R. A., Koliatsos, V. E., et al. (1994) · Science · doi:10.1126/science.7973664 · Cited by 1,272
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons
Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A., Jessell, T. M., Wichterle, H., & Przedborski, S. (2007) · Nature Neuroscience · doi:10.1038/nn1876 · Cited by 1,220
Björklund, L. M., Sánchez-Pernaute, R., Chung, S., Andersson, T., Chen, I. Y. C., McNaught, K. S. P., Brownell, A.-L., Jenkins, B. G., Wahlestedt, C., Kim, K.-S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022438099 · Cited by 1,170
Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., McMahon, A. P., Doucette, W., Siwek, D., Ferrante, R. J., et al. (2003) · Science · doi:10.1126/science.1086071 · Cited by 1,100
Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model
Kaspar, B. K., Lladó, J., Sherkat, N., Rothstein, J. D., & Gage, F. H. (2003) · Science · doi:10.1126/science.1086137 · Cited by 872
Howland, D. S., Liu, J., She, Y., Goad, B., Maragakis, N. J., Kim, B., Erickson, J., Kulik, J., DeVito, L., Psaltis, G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032539299 · Cited by 841
Roy, N. S., Cleren, C., Singh, S. K., Yang, L., Beal, M. F., & Goldman, S. A. (2006) · Nature Medicine · doi:10.1038/nm1495 · Cited by 821
Non–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS model
Di Giorgio, F. P., Carrasco, M. A., Siao, M. C., Maniatis, T., & Eggan, K. (2007) · Nature Neuroscience · doi:10.1038/nn1885 · Cited by 799 · cited 1×
“. Most of the studies to date have focused on modulating the ratio of mutant SOD1 over expression and normal cells in transgenic mice and have shown that reducing the number of glia expressing the mutation can have a significant impact on motor neuron survival and disease progression”
BackgroundBeers, D. R., Henkel, J. S., Xiao, Q., Zhao, W., Wang, J., Yen, A. A., Siklos, L., McKercher, S. R., & Appel, S. H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607423103 · Cited by 733
Palmer, T. D., Ray, J., & Gage, F. H. (1995) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1995.1035 · Cited by 697
Pun, S., Santos, A. F., Saxena, S., Xu, L., & Caroni, P. (2006) · Nature Neuroscience · doi:10.1038/nn1653 · Cited by 658
Williamson, T. L., & Cleveland, D. W. (1999) · Nature Neuroscience · doi:10.1038/4553 · Cited by 637
Henkel, J. S., Engelhardt, J. I., Siklós, L., Simpson, E. P., Kim, S. H., Pan, T., Goodman, J. C., Siddique, T., Beers, D. R., & Appel, S. H. (2004) · Annals of Neurology · doi:10.1002/ana.10805 · Cited by 559
Hall, E. D., Oostveen, J. A., & Gurney, M. E. (1998) · Glia · doi:10.1002/(sici)1098-1136(199807)23:3<249::aid-glia7>3.0.co;2-# · Cited by 489
Svendsen, C. N., Caldwell, M. A., Shen, J., ter Borg, M. G., Rosser, A. E., Tyers, P., Karmiol, S., & Dunnett, S. B. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6634 · Cited by 440
Self-citationJulien, J.-P. (2001) · Cell · doi:10.1016/s0092-8674(01)00244-6 · Cited by 434
Gould, T. W., Buss, R. R., Vinsant, S., Prevette, D., Sun, W., Knudson, C. M., Milligan, C. E., & Oppenheim, R. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2315-06.2006 · Cited by 396
IGF-I specifically enhances axon outgrowth of corticospinal motor neurons
Özdinler, P. H., & Macklis, J. D. (2006) · Nature Neuroscience · doi:10.1038/nn1789 · Cited by 341 · cited 1×
“An interesting recent study showed that in a viral model of motor neuron degeneration, axonal outgrowth and attachment to the muscle could be achieved from transplanted motor neurons by using GDNF secreting cells implanted into the sciatic nerve [56] and that insulin-like growth factor 1 (IGF1) may have specific effec…”
BackgroundA role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis
Barbeito, L. H., Pehar, M., Cassina, P., Vargas, M. R., Peluffo, H., Viera, L., Estévez, A. G., & Beckman, J. S. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.05.003 · Cited by 327
Svendsen, C. N., Clarke, D. J., Rosser, A. E., & Dunnett, S. B. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0039 · Cited by 306
Self-citationOstenfeld, T., Caldwell, M. A., Prowse, K. R., Linskens, M. H., Jauniaux, E., & Svendsen, C. N. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7427 · Cited by 304
Self-citationDeglon, N., Tseng, J. L., Bensadoun, J.-C., Zurn, A. D., Arsenijevic, Y., Almeida, L. P. D., Zufferey, R., Trono, D., & Aebischer, P. (2000) · Human Gene Therapy · doi:10.1089/10430340050016256 · Cited by 292
Self-citationAndersen, P. M., Sims, K. B., Xin, W. W., Kiely, R., O'Neill, G., Ravits, J., Pioro, E., Harati, Y., Brower, R. D., Levine, J. S., et al. (2003) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820310011700 · Cited by 282
Recovery from paralysis in adult rats using embryonic stem cells
Deshpande, D. M., Kim, Y., Martinez, T., Carmen, J., Dike, S., Shats, I., Rubin, L. L., Drummond, J., Krishnan, C., Hoke, A., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20901 · Cited by 272
GDNF Delivery Using Human Neural Progenitor Cells in a Rat Model of ALS
Klein, S. M., Behrstock, S., McHugh, J., Hoffmann, K., Wallace, K., Suzuki, M., Aebischer, P., & Svendsen, C. N. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.509 · Cited by 265
Self-citationHuman Neural Stem Cell Grafts Ameliorate Motor Neuron Disease in SOD-1 Transgenic Rats
Xu, L., Yan, J., Chen, D., Welsh, A. M., Hazel, T., Johe, K., Hatfield, G., & Koliatsos, V. E. (2006) · Transplantation · doi:10.1097/01.tp.0000235532.00920.7a · Cited by 258
Hitoshi, S., Tropepe, V., Ekker, M., & van der Kooy, D. (2002) · Development · doi:10.1242/dev.129.1.233 · Cited by 232
Nikkhah, G., Olsson, M., Eberhard, J., Bentlage, C., Cunningham, M. G., & Bjo¨rklund, A. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90007-8 · Cited by 213
Regional specification of rodent and human neurospheres
Ostenfeld, T., Joly, E., Tai, Y.-T., Peters, A., Caldwell, M., Jauniaux, E., & Svendsen, C. N. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(01)00291-7 · Cited by 203
Self-citationExcitotoxicity and Amyotrophic Lateral Sclerosis
van Cutsem, P., Dewil, M., Robberecht, W., & van den Bosch, L. (2005) · Neurodegenerative Diseases · doi:10.1159/000089620 · Cited by 192
Acsadi, G., Anguelov, R. A., Yang, H., Toth, G., Thomas, R., Jani, A., Wang, Y., Ianakova, E., Mohammad, S., Lewis, R. A., et al. (2002) · Human Gene Therapy · doi:10.1089/104303402753812458 · Cited by 181
Gene expression in human neural stem cells: effects of leukemia inhibitory factor
Wright, L. S., Li, J., Caldwell, M. A., Wallace, K., Johnson, J. A., & Svendsen, C. N. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01826.x · Cited by 168
Self-citationBehrstock, S., Ebert, A., McHugh, J., Vosberg, S., Moore, J., Schneider, B., Capowski, E., Hei, D., Kordower, J., Aebischer, P., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302679 · Cited by 168
Self-citationMohajeri, M. H., Figlewicz, D. A., & Bohn, M. C. (1999) · Human Gene Therapy · doi:10.1089/10430349950017536 · Cited by 148
GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice
Sagot, Y., Tan, S., Hammang, J. P., Aebischer, P., & Kato, A. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02335.1996 · Cited by 141
Self-citationAnterograde Axonal Transport, Transcytosis, and Recycling of Neurotrophic Factors
von Bartheld, C. S., Wang, X., & Butowt, R. (2001) · Molecular Neurobiology · doi:10.1385/mn:24:1-3:001 · Cited by 133
Li, W., Brakefield, D., Pan, Y., Hunter, D., Myckatyn, T. M., & Parsadanian, A. S. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.028 · Cited by 126
Leitner, M. L., Molliver, D. C., Osborne, P. A., Vejsada, R., Golden, J. P., Lampe, P. A., Kato, A. C., Milbrandt, J., & Johnson, E. M. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09322.1999 · Cited by 122
Ganel, R., Ho, T. W., Maragakis, N. J., Jackson, M. T., Steiner, J. P., & Rothstein, J. D. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.014 · Cited by 109
Garbuzova-Davis, S. N., Willing, A. E., Milliken, M., Saporta, S., Žigová, T., Cahill, D. W., & Sanberg, P. R. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7860 · Cited by 100
IAPs are essential for GDNF-mediated neuroprotective effects in injured motor neurons in vivo
Perrelet, D., Ferri, A., Liston, P., Muzzin, P., Korneluk, R. G., & Kato, A. (2002) · Nature Cell Biology · doi:10.1038/ncb751 · Cited by 91
Sexual dimorphism in disease onset and progression of a rat model of ALS
Suzuki, M., Tork, C. A., Shelley, B., McHugh, J., Wallace, K., Klein, S. M., Lindstrom, M. J., & Svendsen, C. N. (2007) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960600982447 · Cited by 79
Self-citationCapowski, E. E., Schneider, B. L., Ebert, A. D., Seehus, C. R., Szulc, J., Zufferey, R., Aebischer, P., & Svendsen, C. N. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2007.02.022 · Cited by 75
Self-citationStem cells for Parkinson disease and ALS: replacement or protection?
Svendsen, C. N., & Langston, J. W. (2004) · Nature Medicine · doi:10.1038/nm0304-224 · Cited by 71
Self-citationWatanabe, K., Nakamura, M., Iwanami, A., Fujita, Y., Kanemura, Y., Toyama, Y., & Okano, H. (2004) · Developmental Neuroscience · doi:10.1159/000082144 · Cited by 70
Rakowicz, W., Staples, C. S., Milbrandt, J., Brunstrom, J. E., & Johnson, E. M. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-10-03953.2002 · Cited by 60
Hemendinger, R. A., Wang, J., Malik, S. Z., Persinski, R., Copeland, J., Emerich, D. F., Gores, P. F., Halberstadt, C. R., & Rosenfeld, J. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.07.025 · Cited by 60
Arvidsson, A., Kirik, D., Lundberg, C., Mandel, R. J., Andsberg, G., Kokaia, Z., & Lindvall, O. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.002 · Cited by 53
Guillot, S., Azzouz, M., Déglon, N., Zurn, A. D., & Aebischer, P. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.01.017 · Cited by 51
Self-citationGLT-1 glutamate transporter levels are unchanged in mice expressing G93A human mutant SOD1
Deitch, J. S., Alexander, G. M., Valle, L. D., & Heiman-Patterson, T. D. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00656-6 · Cited by 27
Cited by
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196
GDNF, NGF and BDNF as Therapeutic Options for Neurodegeneration
Allen, S. J., Watson, J. J., Shoemark, D. K., Barua, N. U., & Patel, N. K. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.004 · Cited by 820
“However, in vivo the beneficial effects were less consistent (Mohajeri et al., 1999; Suzuki et al., 2007; Park et al., 2009).”
BackgroundA comprehensive review of amyotrophic lateral sclerosis
Zarei, S., Carr, K., Reiley, L., Diaz, K., Guerra, O., Altamirano, P., Pagani, W., Lodin, D., Orozco, G., & Chinea, A. (2015) · Surgical Neurology International · doi:10.4103/2152-7806.169561 · Cited by 709
Stem cells in human neurodegenerative disorders — time for clinical translation?
Lindvall, O., & Kokaia, Z. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40543 · Cited by 614
Mesenchymal stem cells for the treatment of neurodegenerative disease
Joyce, N., Annett, G., Wirthlin, L., Olson, S., Bauer, G., & Nolta, J. A. (2010) · Regenerative Medicine · doi:10.2217/rme.10.72 · Cited by 501
Metadata
- Authors
- Suzuki, M., McHugh, J., Tork, C., Shelley, B., Klein, S. M., Aebischer, P., & Svendsen, C. N.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-08-01
- Volume
- 2
- Issue
- 8
- Pages
- e689
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2150994376
- Cited by
- 311
- References
- 59
- FWCI
- 14.13
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.